MedTrace Logo

Guishen Yijing Formula for Diminished Ovarian Reserve: A Real-World Retrospective Study

NCT07660692 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 126

Last updated 2026-08-14

No results posted yet for this study

Summary

The goal of this observational study is to learn about the real-world effectiveness of Guishen Yijing Formula in women with diminished ovarian reserve (DOR). The main question it aims to answer is:

Does Guishen Yijing Formula improve ovarian reserve function in women with DOR after 3 months of treatment? Medical records of participants who received Guishen Yijing Formula as part of their routine clinical care for DOR will be reviewed. Changes in anti-Müllerian hormone (AMH), follicle-stimulating hormone (FSH), and symptom scores before and after treatment will be analyzed.

Conditions

  • Diminished Ovarian Reserve (DOR)

Interventions

DRUG

Guishen Yijing Formula(Chinese herbal decoction)

Sponsors & Collaborators

  • Shi Yun

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-29
Primary Completion
2025-05-30
Completion
2025-05-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07660692 on ClinicalTrials.gov